| Clinical data | |
|---|---|
| Trade names | Neiromidin |
| Other names | Amiridine; NIK-247 |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.201.385 |
| Chemical and physical data | |
| Formula | C12H16N2 |
| Molar mass | 188.274 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ipidacrine (Neiromidin) is a drug first synthesized by the National Research Center for Biologically Active Compounds in theRussian Federation. This compound is a modification of the older drugtacrine (Cognex).[1]
Ipidacrine is a reversibleacetylcholinesterase inhibitor used in memory disorders of different origins.[2][3][4]
Ipidacrine directly stimulates impulse transmission in thecentral nervous system and neuromuscular synapses by blocking membranepotassium channels. Ipidacrine enhances not onlycholine, but alsoadrenaline,serotonin,histamine, andoxytocin effects on smooth muscle.[5]